Muscle Gene Therapy for Hemophilia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of genetic syndrome & gene therapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2157-7412.S1-010PMID 24883231PMCID PMC4038336
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation.

  2012cited by this paper
• Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues.

  2012cited by this paper
• Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

  2012cited by this paper
• Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

  2012cited by this paper
• Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.

  2012cited by this paper
• The principal results of the International Immune Tolerance Study: a randomized dose comparison.

  2012cited by this paper
• Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro

  2012cited by this paper
• Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.

  2012cited by this paper
• Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer.

  2012cited by this paper
• Humoral Immunity to AAV-6, 8, and 9 in Normal and Dystrophic Dogs

  2012cited by this paper
• Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy.

  2012influential reference
• Derivation and characterization of progenitor stem cells from canine allantois and amniotic fluids at the third trimester of gestation.

  2012cited by this paper
• Animal models of hemophilia.

  2012cited by this paper
• Safety of Liver Gene Transfer Following Peripheral Intravascular Delivery of Adeno-Associated Virus (AAV)-5 and AAV-6 in a Large Animal Model

  2011cited by this paper
• Human Mesenchymal Stem Cells from Chorionic Villi and Amniotic Fluid are not Susceptible to Transformation after Extensive in Vitro Expansion

  2011cited by this paper
• Autologous Transplantation of Amniotic Fluid-Derived Mesenchymal Stem Cells into Sheep Fetuses

  2011cited by this paper
• Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice.

  2011cited by this paper
• Gene therapy for haemophilia: a long and winding road

  2011cited by this paper
• Immune responses to AAV in clinical trials.

  2011cited by this paper
• Hemophilia gene therapy: a Holy Grail found.

  2011cited by this paper
• Correction of the coagulation defect in hemophilia using a factor Xa variant with novel engineered protease function

  2011cited by this paper
• Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid

  2011cited by this paper
• Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

  2011cited by this paper
• Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep

  2011cited by this paper
• Gene transfer to muscle from the isolated regional circulation.

  2011cited by this paper
• Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.

  2011cited by this paper
• Bone marrow stem cells and liver regeneration.

  2010cited by this paper
• Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

  2010cited by this paper
• Stages in the development of the ovine immune system.

  2010cited by this paper
• Platelets as delivery systems for disease treatments.

  2010cited by this paper
• Clinical issues in inhibitors

  2010cited by this paper
• Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B

  2010cited by this paper
• Functional aspects of factor VIII expression after transplantation of genetically‐modified hematopoietic stem cells for hemophilia A

  2010cited by this paper
• Lack of immunotoxicity after regional intravenous (RI) delivery of rAAV to nonhuman primate skeletal muscle.

  2010cited by this paper
• Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B.

  2010cited by this paper
• Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs

  2010influential reference
• Clinical and molecular characterization of a re‐established line of sheep exhibiting hemophilia A

  2010cited by this paper
• Long-Term Luciferase Expression Monitored by Bioluminescence Imaging After Adeno-Associated Virus-Mediated Fetal Gene Delivery in Rhesus Monkeys (Macaca mulatta)

  2010cited by this paper
• Stem cell and genetic therapies for the fetus.

  2010cited by this paper
• X-linked thrombophilia with a mutant factor IX (factor IX Padua).

  2009influential reference
• Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation.

  2009cited by this paper
• Update on Procedure-Related Risks for Prenatal Diagnosis Techniques

  2009cited by this paper
• Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.

  2009cited by this paper
• Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.

  2009cited by this paper
• Transplantation with survivin‐engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction

  2009cited by this paper
• Generation of tissue-specific cells from MSC does not require fusion or donor-to-host mitochondrial/membrane transfer.

  2009cited by this paper
• AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

  2009cited by this paper
• Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma.

  2009cited by this paper
• Strategies to modulate immune responses: a new frontier for gene therapy.

  2009cited by this paper
• Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

  2009cited by this paper
• Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect

  2009cited by this paper
• Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteins

  2009cited by this paper
• Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.

  2009cited by this paper
• Rapid hepatic fate specification of adipose‐derived stem cells and their therapeutic potential for liver failure

  2009cited by this paper
• Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging.

  2009cited by this paper
• Potential of mesenchymal stem cells as immune therapy in solid‐organ transplantation

  2009cited by this paper
• Successful treatment of canine hemophilia by continuous expression of canine FVIIa.

  2009cited by this paper
• Ten years of gene therapy for primary immune deficiencies.

  2009cited by this paper
• Inhibitors in factor IX deficiency a report of the ISTH‐SSC international FIX inhibitor registry (1997–2006)

  2009cited by this paper
• In vivo models of haemophilia – status on current knowledge of clinical phenotypes and therapeutic interventions

  2008cited by this paper
• Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells

  2008cited by this paper
• Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle.

  2008cited by this paper
• Expression of Molecules Involved in Fetal-Maternal Tolerance Allows Human Mesenchymal Stem Cells to Engraft at High Levels across Immunologic Barriers

  2008cited by this paper
• Cell-based therapies for metabolic liver disease.

  2008cited by this paper
• Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells.

  2008cited by this paper
• In utero hematopoietic stem cell transplantation: progress toward clinical application.

  2008cited by this paper
• Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo

  2008cited by this paper
• A Frame Shift-Induced Stop Codon Causes Hemophilia a in Sheep.

  2008cited by this paper
• Tales from the Crypt: Mesenchymal Stem Cells for Replenishing the Intestinal Stem Cell Pool

  2008cited by this paper
• Fetal stem-cell transplantation.

  2008cited by this paper
• Comparison Between Adenoviral and Retroviral Vectors for the Transduction of the Thymidine Kinase PET Reporter Gene in Rat Mesenchymal Stem Cells

  2008cited by this paper
• Transformation by Retroviral Vectors of Bone Marrow‐Derived Mesenchymal Cells Induces Mitochondria‐Dependent cAMP‐Sensitive Reactive Oxygen Species Production

  2008cited by this paper
• Lentiviral‐Transduced Human Mesenchymal Stem Cells Persistently Express Therapeutic Levels of Enzyme in a Xenotransplantation Model of Human Disease

  2008cited by this paper
• Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.

  2008cited by this paper
• Progress in the molecular biology of inherited bleeding disorders

  2008cited by this paper
• Factors Determining the Risk of Inadvertent Retroviral Transduction of Male Germ Cells After In Utero Gene Transfer in Sheep

  2008cited by this paper
• Intra-portal transplantation of bone marrow stromal cells ameliorates liver fibrosis in mice.

  2008cited by this paper
• Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

  2008cited by this paper
• Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice

  2008cited by this paper
• IFATS Collection: In Vivo Therapeutic Potential of Human Adipose Tissue Mesenchymal Stem Cells After Transplantation into Mice with Liver Injury

  2008cited by this paper
• Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity.

  2008cited by this paper
• Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep

  2007cited by this paper
• Evidence for an immune barrier after in utero hematopoietic-cell transplantation.

  2007cited by this paper
• Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

  2007cited by this paper
• Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat

  2007cited by this paper
• Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

  2007cited by this paper
• Emerging role of regulatory T cells in gene transfer.

  2007cited by this paper
• Adeno-associated viral vector transduction of human mesenchymal stem cells.

  2007cited by this paper
• In Vivo Distribution of Human Adipose‐Derived Mesenchymal Stem Cells in Novel Xenotransplantation Models

  2007cited by this paper
• The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells1

  2007cited by this paper
• Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells

  2007cited by this paper
• Bone marrow–derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice

  2007cited by this paper
• Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.

  2007cited by this paper
• Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells Through an Interleukin‐6‐Dependent Mechanism

  2007cited by this paper
• Re-Establishment and Characterization of an Extinct Line of Sheep with a Spontaneous Bleeding Disorder That Closely Recapitulates Human Hemophilia A.

  2007cited by this paper
• Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity.

  2007cited by this paper
• Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo.

  2007cited by this paper
• Immune responses to AAV in clinical trials.

  2007cited by this paper
• Stem cell transplantation: the lung barrier.

  2007cited by this paper
• The role of indoleamine 2,3‐dioxygenase in transplantation

  2007cited by this paper

• Advances and Challenges in Adeno-Associated Virus Gene Therapy Applications of Localized Delivery Strategies

  2025cites this paper
• Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci

  2024cites this paper
• Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci

  2024cites this paper
• Gene Therapy for Cancer Treatment

  2016cites this paper
• Promising coagulation factor VIII bypassing strategies for patients with haemophilia A

  2014cites this paper
• The Need for Gene Therapy for the Effective Treatment of Hemophilia

  2012cites this paper